Interestingly, selective over-expression of ABCG1 in vivo did not affect Aβ or amyloid levels in the PDAPP mouse model of AD (Burgess et al., 2008), suggesting that over-expression of ABCG1 is unlikely to contribute to the early onset of AD in the DS population. This evidence concerns the gene ABCG1 and Alzheimer disease.